News - April 26, 2021

🎙️Sounds of Science – EUCOPE Podcasts

Today marks the release of the first episode of Sounds of Science, a series of podcasts organized by EUCOPE, discussing pressing EU files and presenting the point of view of EUCOPE and its members in an informative and interactive way. In this first podcast, Ana… read more

Partnerships - March 25, 2021


Working group of European rare disease experts developed  nine principles to foster greater consistency in Value Assessment and Funding Process in rare diseases. The group explored the pricing and reimbursement systems for OMPs in selected European countries to analyse where they align with or diverge from… read more

Partnerships - March 25, 2021


Multi-stakeholder initiative commissioned by the Belgian National Institute of Health and Disability Insurance (INAMI-RIZIV) aimed at fostering stakeholders’ agreement of what real-world data (RWD) can be collected for highly innovative technologies, to generate real-world evidence (RWE) that informs decisions by healthcare systems, clinicians and patients…. read more

Partnerships - March 25, 2021

European Expert Group on OD Incentives

Multidisciplinary expert group including researchers, academia, patient representatives, investors and industry Input to strengthen the OMP Incentives Environment in Europe focusing on addressing unmet needs and supporting delivery of continued innovation where treatments exist; finding ways to optimise and accelerate OD regulatory pathways and identifying… read more

News - March 25, 2021

EUCOPE Statement on Council HTA compromise – March 2021

EUCOPE welcomes the important collaborative effort made by the Council of the EU to reach a compromise on the EU on a Proposal for a Regulation on health technology assessment (HTA) and amending Directive 2011/24/EU. However, we note that the direction of the current compromise… read more